ArticleFrontiers in oncology2025

Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report.

Valentina Di Ruscio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.